Related Experiment Video
Updated: Mar 11, 2026

10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.0K
Cytopathologic and immunophenotypic changes in NUT midline carcinoma after targeted therapy
1Department of Pathology, Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts.
Cancer Cytopathology
|November 19, 2016
Summary
No abstract available in PubMed .

